CSF3 and Decreased total neutrophil count: Granulocyte colony-stimulating factors (G-CSFs), such as filgrastim and its long-acting pegylated form, pegfilgrastim, are widely recommended for primary febrile neutropenia prophylaxis and for maintaining chemotherapy dose intensity in early breast cancer.1-6